Author Affiliation: Dipartimento di Patologia e Medicina di Laboratorio, U.O. di Diagnostica Ematochimica, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
I read with interest the recent article by Morrison et al,1 who concluded that patients with diabetes mellitus who visited a primary care provider every 2 weeks more quickly achieved hemoglobin A1c, blood pressure, and low-density lipoprotein cholesterol targets. It is, however, unclear whether these important results were attributable to the visit itself or, more probably, to the closer monitoring of these parameters. Other than with direct access to physician's visit, medication intensification in patients with diabetes can be achieved by innovative and more comfortable technological pathways of patient-physician communication. A variety of biochemical and clinical features can now be reliably assessed by using real-time networks deploying a variety of sensors.2 The so-called e-alerts and e-advisories can then be generated when needed (eg, e-pill medication reminders) to optimize the expected value to the patient. This approach has already been proven simple and cost-effective for the self-management of patients with a variety of chronic diseases3 and therefore might be reliably experimented in patients with diabetes for providing medication as well as blood pressure and laboratory test reminders.
Lippi G. Better Care for Patients With Diabetes: e-Medicine Is the Goal. Arch Intern Med. 2012;172(4):373. doi:10.1001/archinternmed.2011.783